Tumor Growth Delay Caused by Proton Therapy in Combination with the Vascular Disrupting Agent AVE8062

MLA

Terakawa, A., et al. “Tumor Growth Delay Caused by Proton Therapy in Combination with the Vascular Disrupting Agent AVE8062.” CYRIC Annual Report, vol. 2008, Jan. 2008, pp. 61–64. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.jairo.........e47e8fc8201b7f7c38f0be27ee1b3b3a&authtype=sso&custid=ns315887.

APA

Terakawa, A., Ishii, K., Matsuyama, S., Kikuchi, Y., Akiyama, H., Koyata, K., Ito, Y., Tagawa, A., Yasunaga, S., Yamazaki, H., Tashiro, M., Funaki, Y., Furumoto, S., Itoh, N., Wada, S., & Orihara, H. (2008). Tumor Growth Delay Caused by Proton Therapy in Combination with the Vascular Disrupting Agent AVE8062. CYRIC Annual Report, 2008, 61–64.

Chicago

Terakawa, A., K. Ishii, S. Matsuyama, Y. Kikuchi, H. Akiyama, K. Koyata, Y. Ito, et al. 2008. “Tumor Growth Delay Caused by Proton Therapy in Combination with the Vascular Disrupting Agent AVE8062.” CYRIC Annual Report 2008 (January): 61–64. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.jairo.........e47e8fc8201b7f7c38f0be27ee1b3b3a&authtype=sso&custid=ns315887.